Antimicrobial resistance of Neisseria gonorrhoeae isolated from patients attending sexually transmitted infection clinics in Urban Hospitals, Lusaka, Zambia
- PMID: 35962370
- PMCID: PMC9373640
- DOI: 10.1186/s12879-022-07674-y
Antimicrobial resistance of Neisseria gonorrhoeae isolated from patients attending sexually transmitted infection clinics in Urban Hospitals, Lusaka, Zambia
Abstract
Background: Neisseria gonorrhoeae, the causative agent for sexually transmitted infection (STI) gonorrhoea, has emerged with a significant public health impact on acquiring resistance to antimicrobials available for treatment. The resistance of N. gonorrhoeae limit treatment options and contributed to high morbidity associated with gonorrhoea. Data on antimicrobial resistance (AMR) profiles in N. gonorrhoeae is scares in Zambia. This study aimed to determine the antibiotic susceptibilities in N. gonorrhoeae isolates from Lusaka, Zambia.
Methods: A prospective cross-sectional study was conducted on 630 STI patients who presented with urethral or vaginal discharge from 2019 to 2020. Urethral and endocervical secretions were cultured on Modified Thayer Martin agar and incubated at 36 °C ± 1 °C in 5% CO2 for 24 h. Identification of N. gonorrhoeae isolates was achieved by Gram stain, oxidase, nitrocefin disk, BactiCard Neisseria, and Viteck® Compact. The AMR profiles were determined using E-test. Statistical significant was determined by Pearson's Chi-square test, Mann-Whitney U test, or logistic regression with p-values of < 0.05 indicating significance.
Results: A total of 630 patients were recruited of which 46% (290/630) with the median of 29 years and interquartile range (IQR) of 19-39 years were male. The median of the females was 26 years and IQR of 15-37 years. Neisseria gonorrhoeae was isolated from 19.4% (122/630) patients of which 72.9% (89/122) were male, with highest prevalence of isolation in the age category of 25-34 years. The prevalence of resistance was high to penicillin (85.2%), tetracycline (68.9%) and ciprofloxacin (59.8%) with MIC90 of 32 µg/mL, 8 µg/mL, and 8 µg/mL respectively. The isolates had reduced susceptibility to cefixime (1.6%), spectinomycin (4.9%) and (4.9%) for azithromycin. All isolates were susceptible to ceftriaxone. Risk factors associated with AMR were douching in females (AOR 6.69, 95% CI; 1.11-40.31, p = 0.039), female gender (AOR 7.64, 95% CI; 1.11-52.33, p = 0.048), HIV-positivity (AOR 26.59, 95% CI; 3.67-192.7, p = 0.005), no condom use or unprotected sex (AOR 5.48, 95% CI; 1.17-22.75 p = 0.026), sex trading (AOR 4.19, 95% CI; 1.55-11.33, p = 0.010), and over-counter treatment of ciprofloxacin (AOR 3.44, 95% CI; 1.17-22.75, p = 0.023).
Conclusion: The N. gonorrhoeae resistance to penicillin, tetracycline and ciprofloxacin was high necessitating revision of the treatment guidelines. However, no resistance to ceftriaxone was detected. Therefore, monitoring of antibiotic resistance remains critical in Zambia.
Keywords: Antimicrobial resistance; Epsilometer test; Neisseria gonorrhoeae; Zambia.
© 2022. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
Antimicrobial resistance and heterogeneity of Neisseria gonorrhoeae isolated from patients attending sexually transmitted infection clinics in Lusaka, Zambia.BMC Genomics. 2024 Mar 18;25(1):290. doi: 10.1186/s12864-024-10155-y. BMC Genomics. 2024. PMID: 38500064 Free PMC article.
-
Incidence and antimicrobial susceptibility of Neisseria gonorrhoeae isolates from patients attending the national Neisseria gonorrhoeae reference laboratory of Hungary.BMC Infect Dis. 2014 Aug 6;14:433. doi: 10.1186/1471-2334-14-433. BMC Infect Dis. 2014. PMID: 25098185 Free PMC article.
-
Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014.MMWR Surveill Summ. 2016 Jul 15;65(7):1-19. doi: 10.15585/mmwr.ss6507a1. MMWR Surveill Summ. 2016. PMID: 27414503
-
A systematic review of antimicrobial resistance in Neisseria gonorrhoeae and Mycoplasma genitalium in sub-Saharan Africa.J Antimicrob Chemother. 2022 Jul 28;77(8):2074-2093. doi: 10.1093/jac/dkac159. J Antimicrob Chemother. 2022. PMID: 35578892 Free PMC article.
-
Antimicrobial resistance of Neisseria gonorrhoeae in Latin American countries: a systematic review.J Antimicrob Chemother. 2023 Jun 1;78(6):1322-1336. doi: 10.1093/jac/dkad071. J Antimicrob Chemother. 2023. PMID: 37192385 Free PMC article.
Cited by
-
Neisseria gonorrhoeae antimicrobial resistance patterns and associated risk factors in women of childbearing potential in northwestern Ethiopia.BMC Womens Health. 2024 Jan 31;24(1):82. doi: 10.1186/s12905-024-02898-3. BMC Womens Health. 2024. PMID: 38297305 Free PMC article.
-
Promoting molecular diagnostic equity: assessing in-house real-time PCR for Neisseria gonorrhoeae in anal samples from MSM recruited in an outpatient setting in Morocco.Infez Med. 2024 Sep 1;32(3):352-362. doi: 10.53854/liim-3203-9. eCollection 2024. Infez Med. 2024. PMID: 39282536 Free PMC article.
-
Antimicrobial treatment and resistance in sexually transmitted bacterial infections.Nat Rev Microbiol. 2024 Jul;22(7):435-450. doi: 10.1038/s41579-024-01023-3. Epub 2024 Mar 20. Nat Rev Microbiol. 2024. PMID: 38509173 Review.
-
Tetracycline-resistant Neisseria gonorrhoeae global estimates-impacts on doxycycline post-exposure prophylaxis implementation and monitoring: a systematic review.JAC Antimicrob Resist. 2025 Jul 9;7(4):dlaf120. doi: 10.1093/jacamr/dlaf120. eCollection 2025 Aug. JAC Antimicrob Resist. 2025. PMID: 40636396 Free PMC article. Review.
-
Enhancing Insights into Australia's Gonococcal Surveillance Programme through Stochastic Modelling.Pathogens. 2023 Jul 4;12(7):907. doi: 10.3390/pathogens12070907. Pathogens. 2023. PMID: 37513754 Free PMC article.
References
-
- Unemo M, Lahra MM, Cole M, Mike S, Galarza P, Ndowa F, Martin I, Dillion JR, Ramon-Pardo R, Bolan G, Wi T. World Health Organisation Global Gonococcal Antimicrobial Surveillance Program (WHO GASP): review of new data and evidence to inform international collaborative actions and research efforts. J PubMed Central. 2019;16:412–425. - PMC - PubMed
-
- WHO. Global progress report on HIV, viral hepatitis and sexually transmitted infections, May 20, 2021. https://www.who.int/publications/i/item/9789240027077. Accessed Aug 18, 2021.
-
- World Health Organisation (WHO). WHO guidelines for the treatment of Neisseria gonorrhoeae. Geneva: WHO; 2016. - PubMed
-
- Unemo M, Ross J, Serwin AB, Gomberg M, Cusini M, Jensen JS, Unemo M, Ross J, Serwin AB, Gomberg M, Cusini M, Jensen JS. European guideline for the diagnosis and treatment of gonorrhoea in adults. Int J Sexually Transm Dis Acq Immunodef Dis Syndr. 2020;2020:956462420949126. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical